Bachelor of Science

Mount Royal University and American Canadian School of Medicine sign agreement

Retrieved on: 
Tuesday, January 30, 2024
Partnership, ASCOM, Bachelor of Science, Medical school, Student, Curriculum, Yale University, School, Bachelor, Pennsylvania State University, Kazan, AB, George Washington University, Western University, Faculty, Provost, Physician, MRU, State university system, Health, Royal University, Mount Royal University, Nursing

CALGARY, AB, Jan. 30, 2024 /PRNewswire-PRWeb/ -- Calgary - Mount Royal University (MRU) and American Canadian School of Medicine (ACSOM) and have signed an agreement giving MRU students a new way to work toward their goal of becoming a physician.

Key Points: 
  • Mount Royal University (MRU) and American Canadian School of Medicine (ACSOM) and have signed an agreement giving MRU students a new way to work toward their goal of becoming a physician.
  • CALGARY, AB, Jan. 30, 2024 /PRNewswire-PRWeb/ -- Calgary - Mount Royal University (MRU) and American Canadian School of Medicine (ACSOM) and have signed an agreement giving MRU students a new way to work toward their goal of becoming a physician.
  • Its current partnerships and collaborations include visiting faculty from Yale University, Stoney Brook (State University of New York), Penn State University, George Washington University and Schulich School of Medicine at Western University, among others.
  • "We are thrilled to announce this agreement with Mount Royal University.

Shockwave Medical Appoints Renee Gaeta as Chief Financial Officer

Retrieved on: 
Monday, January 29, 2024
Patient, Therapy, Health, CFO, Certified Public Accountant, IVL, Loyola Marymount University, Bachelor of Science, Cardiovascular disease, Growth, Management

SANTA CLARA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today the appointment of Renee Gaeta as Chief Financial Officer (CFO), effective February 5, 2024.

Key Points: 
  • SANTA CLARA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today the appointment of Renee Gaeta as Chief Financial Officer (CFO), effective February 5, 2024.
  • Renee succeeds Dan Puckett, CFO at Shockwave since 2016, who previously announced his decision to retire.
  • “Renee is a highly skilled and accomplished executive with a proven track record in the medical device and healthcare industries,” said Doug Godshall, Chief Executive Officer at Shockwave.
  • “I am thrilled to welcome Renee to Shockwave and look forward to partnering with her through our next phase of growth and profitability.

Osisko Appoints David Smith to Its Board of Directors

Retrieved on: 
Wednesday, January 24, 2024
Osisko Gold Royalties, Agnico Eagle, Knowledge, Mining, University, University of Arizona, Bachelor of Science, Mining engineering, Engineering, Management

MONTRÉAL, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko” or the “Corporation”) (OR: TSX & NYSE) is pleased to announce the appointment of Mr. David Smith to its Board of Directors.

Key Points: 
  • MONTRÉAL, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (“Osisko” or the “Corporation”) (OR: TSX & NYSE) is pleased to announce the appointment of Mr. David Smith to its Board of Directors.
  • He originally started with Agnico Eagle in 2005, at which time he formalized the company’s Investor Relations program.
  • He is a Chartered Director and is currently the Chair of Canada Nickel Company’s Board of Directors.
  • Mr. Norman MacDonald, Chair of Osisko’s Board of Directors commented: “We are delighted to have David join Osisko’s Board of Directors.

Nevada Canyon Announces Appointment of New Directors

Retrieved on: 
Thursday, January 18, 2024
Diamond, Diavik Diamond Mine, Architecture, Research, Regent's University London, Whistler, Larix laricina, Geology, STS, Bachelor of Science, Bemidji State University, Compensated emancipation, Smith, Engineering, Audit committee, DOD, California State University, Management

Reno, Nevada, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Nevada Canyon Gold Corp. (OTC Markets: NGLD) (the “Company” or “Nevada Canyon”) is pleased to announce the appointment of Mr. John Schaff, B.Sc.

Key Points: 
  • Reno, Nevada, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Nevada Canyon Gold Corp. (OTC Markets: NGLD) (the “Company” or “Nevada Canyon”) is pleased to announce the appointment of Mr. John Schaff, B.Sc.
  • as new independent directors to its Board of Directors, effective immediately.
  • With the appointment of these additional Directors, the Board is now comprised of five (5) directors, of which three (3) are considered independent.
  • “We’re excited to expand our board of directors with these new members who bring both a wealth of experience in Nevada and contacts to the Company,” said Jeffrey Cocks, Chairman of the Board of Directors of the Company.

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

Retrieved on: 
Wednesday, January 24, 2024
Cardiology, Biotechnology, Technology, Other Health, Health, General Health, Health Technology, Medical Devices, Software, Artificial Intelligence, Genetics, Nuclear medicine, Entrepreneurship, Artificial intelligence, Patient, Internal medicine, Research, American College of Physicians, MD, Cardio, Emory University, JACC, Innovation, University, Algorithm, Journal of Clinical Investigation, FACC, ACP, ACC, Journal, NIH, Cardiovascular disease, Bachelor of Science, Hospital, Society for Vascular Surgery, Mount Sinai School, American College, Growth, Medical device

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the appointment of Dr. Vimal Ramjee, MD FACC CCMS , as a Strategic Advisor.

Key Points: 
  • Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the appointment of Dr. Vimal Ramjee, MD FACC CCMS , as a Strategic Advisor.
  • The appointment of Dr. Ramjee as a Strategic Advisor to Cardio Diagnostics is a significant development to the Company’s continued growth and market expansion.
  • “I am excited to join Cardio Diagnostics and contribute to the company’s mission of improving cardiovascular health,” said Dr. Ramjee.
  • Dr. Ramjee will also work to raise awareness of Cardio Diagnostics’ innovative technologies and their potential to improve patient care.

Tris Pharma Appoints Franchesca Fowler to Chief Compliance Officer and Vice President, General Counsel

Retrieved on: 
Monday, January 22, 2024
Biotechnology, Neurology, Mental Health, Health, Pharmaceutical, Ketan, Patient, Pharma, JD, IP, Fordham University, Rutgers Law School, Culture, Addiction, Attention deficit hyperactivity disorder, Pain, DSM-IV codes, Bachelor of Science, Pharmaceutical industry

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced the appointment of Franchesca Fowler, JD, as chief compliance officer and vice president, general counsel.

Key Points: 
  • Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced the appointment of Franchesca Fowler, JD, as chief compliance officer and vice president, general counsel.
  • Ms. Fowler will oversee all legal matters within the company, including legal compliance, IP management, litigation and more.
  • Ms. Fowler received her Bachelor of Science in Finance from Fordham University and her Juris Doctor degree from Rutgers Law School.
  • “My decision to join Tris Pharma was driven not only by its exciting pipeline and growth prospects, but also the exceptional team of dedicated professionals.

Pivotree Appoints Cliff Isaacson to Chief Product Officer

Retrieved on: 
Thursday, January 18, 2024
Technology, Other Retail, Other Technology, Software, Networks, Internet, Data Management, Supply Chain Management, Retail, Online Retail, Tepper School of Business, CUSIP, Cliff, PVT, Data management, Industrial, Business, Carnegie Mellon University, Computer science, Acquisition, Bachelor of Science, Product strategy, TSX Venture Exchange, Master of Science, Roper Technologies, Inc., Growth

Pivotree Inc. (TSXV: PVT) (“Pivotree''), a leading provider of frictionless commerce solutions and services, today announced the appointment of Cliff Isaacson as Chief Product Officer.

Key Points: 
  • Pivotree Inc. (TSXV: PVT) (“Pivotree''), a leading provider of frictionless commerce solutions and services, today announced the appointment of Cliff Isaacson as Chief Product Officer.
  • As Chief Product Officer, Cliff Isaacson will be responsible for building winning product strategies focused on the evolution of existing products and supporting the development of new products.
  • He will lead product teams and manage the overall solution introduction and product strategy for Pivotree.
  • “We are thrilled to welcome Cliff Isaacson to Pivotree," said Bill Di Nardo, CEO of Pivotree.

SightMD New York Welcomes Clearview Eye Surgery to It's Expert Team

Retrieved on: 
Thursday, January 25, 2024
Family, Patient, Cataract, United States Army, Blepharoplasty, Health, Contact, Trust, Stony Brook University, Partnership, Retina, Eye, Retinal, Communication, Diabetic retinopathy, PHD, Macular degeneration, Strabismus, Suite, Acquisition, Bachelor of Science, Glaucoma, DSM-IV codes, OD, Gettysburg College, Diagnosis, Physician

HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery. Through this strategic partnership Clearview's practice locations at 1825 Riverside Drive, Suite 1B New York, NY 10034, 1200 Waters Place, Suite 304 Bronx, NY 10461 and 132-15 41st Avenue CC Flushing , NY 11355 will expand SightMD's presence by adding three locations and five providers, growing SightMD's current footprint to 40+ locations and 85+ providers across New York.

Key Points: 
  • HAUPPAUGE, N.Y., Jan. 25, 2024 /PRNewswire-PRWeb/ -- SightMD New York, a leading multi-specialty ophthalmology platform, announced a strategic partnership with Clearview Eye Surgery.
  • - Dr. John J. Kim, Founder of Clearview Eye Surgery
    "We are excited to welcome Clearview Eye Surgery into the SightMD family.
  • Clearview Eye Surgery is dedicated to providing state of the art, professional and personalized eye care to all of our patients to ensure the best possible outcome.
  • Thousands of people have trusted their award-winning team with their families' eye care and vision correction treatment, and we are grateful for the opportunity to have them join the expert team at SightMD.

CCRM FERTILITY ANNOUNCES CHELSEY LEISINGER AS NEW VP OF NETWORK LAB COMPLIANCE

Retrieved on: 
Monday, January 22, 2024
Patient, Fertility, Research, Iowa State University, IVF, Science, Embryology, University School, Bachelor of Science, Laboratory, Certification, Doctor of Philosophy, Veterinary medicine, University college, Medical device

LONE TREE, Colo., Jan. 22, 2024 /PRNewswire/ -- CCRM Fertility, a leading pioneer in the fertility treatment, research, and science industry, announced today the appointment of Chelsey Leisinger, MS, PhD, HCLD/CC as VP of Network Lab Compliance.

Key Points: 
  • Dr. Leisinger joins CCRM's leading team of fertility specialists, focusing on laboratory compliance
    LONE TREE, Colo., Jan. 22, 2024 /PRNewswire/ -- CCRM Fertility, a leading pioneer in the fertility treatment, research, and science industry, announced today the appointment of Chelsey Leisinger, MS, PhD, HCLD/CC as VP of Network Lab Compliance.
  • As the newly appointed Vice President of Network Lab Compliance for CCRM, Dr. Leisinger, a renowned fertility specialist, will play a pivotal role in supervising select laboratory locations.
  • Her primary focus will be on ensuring laboratory compliance and risk mitigation, thereby elevating the fertility experience for both CCRM laboratory technologists and patients.
  • "I am thrilled to join the CCRM Fertility expert team to help further the mission of providing top-notch fertility care," said Dr. Leisinger.

ImmunoBrain Checkpoint Appoints Dr. Sanjay Keswani as Chief Executive Officer

Retrieved on: 
Monday, January 22, 2024
Bristol Myers Squibb, Neurophysiology, Patient, MD, Sanjay, Medicine, St Bartholomew's Hospital, Johns Hopkins Hospital, Johns Hopkins, Royal College of Physicians, Immunology, Saint Mary's Hospital, Acquisition, Royal college, Bachelor of Science, CMO, IPO, Bartholomew the Apostle, Fibrosis, Hospital, Series A round, FRCP, Roche, Faricimab, Growth, Pharmaceutical industry

NEW YORK, Jan. 22, 2024 /PRNewswire/ -- ImmunoBrain Checkpoint Inc. (ImmunoBrain), a clinical stage biopharmaceutical company developing innovative disease-modifying immune therapies to combat neurodegenerative diseases, today announced the appointment of Dr. Sanjay Keswani, MD, BSc, FRCP, as its President and Chief Executive Officer.

Key Points: 
  • NEW YORK, Jan. 22, 2024 /PRNewswire/ -- ImmunoBrain Checkpoint Inc. (ImmunoBrain), a clinical stage biopharmaceutical company developing innovative disease-modifying immune therapies to combat neurodegenerative diseases, today announced the appointment of Dr. Sanjay Keswani, MD, BSc, FRCP, as its President and Chief Executive Officer.
  • Dr. Keswani is an accomplished physician-scientist with executive leadership experience in both large pharma and small biotech companies.
  • "As a physician-scientist and seasoned biotech executive, Dr. Keswani possesses both the business acumen and the R&D expertise required to serve as Chief Executive Officer of ImmunoBrain," stated Nathan Hevrony, Co-founder and Executive Chairman of ImmunoBrain.
  • I am privileged to work with the ImmunoBrain team and Professor Michal Schwartz whose groundbreaking seminal research has formed the foundation of ImmunoBrain," stated Dr. Sanjay Keswani.